SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CERAGENIX PHAMACEUTICALS INC
(NQPK:CGXP Last Sale: .0013 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details


NQPK: (CGXP : $.0013)
$0 million Market Cap at September 11, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today

1444 Wazee Street Research Report Earnings Snapshot - Last
Suite 210
Denver, CO 80202
Phone: 303-534-1800

Steven S. Porter, CEO
Biopharmaceutical company focused on dermatology and infectious disease.
Historical Charts    Technical Analysis
No Historical Data available for CGXP

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CGXP $.0013 $ 0 $.0013 $.0013 11,000 $.001 $.0065 18,303
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $24

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex